Novelix Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 36.92 | 25.19 | 48.40 |
| Operating Expense | 35.61 | 23.91 | 47.09 |
| Net Profit | 1.18 | 0.91 | 1 |
| Net Profit Margin | 3.20% | 3.61% | 2.07% |
| Earning Per Share | 0.49 | 0.43 | 0.58 |
| EBIDTA | 1.63 | 1.29 | 1.32 |
| Effective Tax Rate | 20% | 25.78% | 22.14% |
Particulars
Jun 2026
Revenue36.92
Operating Expense35.61
Net Profit1.18
Net Profit Margin3.20
Earning Per Share0.49
EBIDTA1.63
Effective Tax Rate20
